Clinical Trials Browser

Phase 2 × tenalisib × Breast × Clear all

NCT06189209 2025-12-02

Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT05021900 2024-08-13

Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

40 enrolled 12 charts

Breast Neoplasms